CoreCivic’s second quarter was marked by strong revenue growth and outperformance relative to Wall Street expectations, with management citing increased occupancy rates and higher demand from its federal government partners as primary drivers. CEO Patrick Swindle highlighted the significant activation of previously idle facilities and the completion of new management contracts, particularly with U.S. Immigration and Customs Enforcement (ICE). The quarter also benefited from the acquisition of Clinical Solutions Pharmacy and contributions from new contracts, as well as a favorable shift in revenue mix toward ICE-related services.
Is now the time to buy CXW? Find out in our full research report (it’s free for active Edge members).
CoreCivic (CXW) Q2 CY2026 Highlights:
- Revenue: $684.9 million vs analyst estimates of $617.7 million (27.3% year-on-year growth, 10.9% beat)
- Adjusted EPS: $0.38 vs analyst estimates of $0.34 (11.8% beat)
- Adjusted EBITDA: $109.4 million vs analyst estimates of $108.4 million (16% margin, 0.9% beat)
- Management raised its full-year Adjusted EPS guidance to $1.66 at the midpoint, a 5.1% increase
- EBITDA guidance for the full year is $443 million at the midpoint, below analyst estimates of $454.1 million
- Operating Margin: 10.1%, down from 12% in the same quarter last year
- Market Capitalization: $3.35 billion
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From CoreCivic’s Q2 Earnings Call
-
Greg Gibas (Northland Securities) asked about the EBITDA guidance impact from contract renegotiations tied to recent facility sales. CFO David Garfinkle said guidance incorporates a range of outcomes, but specifics are withheld due to ongoing negotiations.
-
Marla Marin (Zacks) questioned whether preliminary asset sale talks with ICE would pause share repurchases. Garfinkle explained repurchases depend on negotiation status and open trading windows, but the intention is to resume buybacks when possible.
-
William Sutherland (Benchmark) inquired about the margin profile of the newly activated Prairie facility. Garfinkle responded that margins should be consistent with other ICE contracts across the portfolio.
-
Edwin Groshans (Compass Point Research and Trading) pressed for clarity on CoreCivic’s ability to reactivate idle capacity amid rising ICE apprehensions. Swindle said the company is well positioned with ready-to-activate facilities but cautioned on projecting the timing of additional activations.
-
Joseph Anthony Gomes (Noble Capital) asked about per diem increases in state contracts and future demand from state and U.S. Marshals customers. Swindle confirmed state-level per diem adjustments and said trends are consistent with historical seasonal patterns.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be monitoring (1) the pace at which newly activated facilities reach target occupancy and contribute to margins, (2) the outcome of contract renegotiations following recent asset sales and their effect on revenue visibility, and (3) CoreCivic’s ability to deploy capital through the expanded share repurchase program without disrupting leverage targets. Further developments in ICE enforcement and potential new asset sales could also influence long-term strategic direction.
CoreCivic currently trades at $33.63, up from $31.23 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).
The Best Stocks for High-Quality Investors
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.